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Abstract
Artemisinin, a thapsigargin-like sesquiterpene has been shown to inhibit the Plasmodium falciparum sarco/endoplasmic
reticulum calcium-ATPase PfSERCA. To collect baseline pfserca sequence information before field deployment of
Artemisinin-based Combination therapies that may select mutant parasites, we conducted a sequence analysis of 100
isolates from multiple sites in Africa, Asia and South America. Coding sequence diversity was large, with 29 mutated codons,
including 32 SNPs (average of one SNP/115 bp), of which 19 were novel mutations. Most SNP detected in this study were
clustered within a region in the cytosolic head of the protein. The PfSERCA functional domains were very well conserved,
with non synonymous mutations located outside the functional domains, except for the S769N mutation associated in
French Guiana with elevated IC50 for artemether. The S769N mutation is located close to the hinge of the headpiece, which
in other species modulates calcium affinity and in consequence efficacy of inhibitors, possibly linking calcium homeostasis
to drug resistance. Genetic diversity was highest in Senegal, Brazil and French Guiana, and few mutations were identified in
Asia. Population genetic analysis was conducted for a partial fragment of the gene encompassing nucleotide coordinates
87-2862 (unambiguous sequence available for 96 isolates). This supported a geographic clustering, with a separation
between Old and New World samples and one dominant ancestral haplotype. Genetic drift alone cannot explain the
observed polymorphism, suggesting that other evolutionary mechanisms are operating. One possible contributor could be
the frequency of haemoglobinopathies that are associated with calcium dysregulation in the erythrocyte.
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Introduction
Plasmodium falciparum malaria claims close to one million deaths
every year, mainly in sub-Saharan African children. To face
increasing anti-malarial treatment failure, many countries have
adopted artemisinin-based combination therapy (ACT) [1].
However there are concerns about emerging resistance to
artemisinin derivatives, with in vitro drug resistance to artemether
reported in French Guiana and northern Brazil [2–3] and high in
vivo tolerance evidenced by delayed parasite clearance emerging in
Cambodia [4–8]. The mechanism of action of artemisinin
derivatives and the molecular basis of artemisinin resistance
and/or tolerance are poorly understood. It has been recently
proposed that artemisinins inhibit PfSERCA, the P. falciparum
Sarco(endo)plasmic reticulum Ca2+ATPase [9–10], and thus
possibly act by perturbing calcium homeostasis of the intracellular
parasite.
SERCA,thecalciumpumpofsarcoplasmicreticulumresponsible
for refilling calcium in the ER stores is critically important for
cellular homeostasis and calcium signalling functions [11–13].
Unlike vertebrates that possess three serca genes [14], P. falciparum
has a single SERCA, originally described as PfATPase6 [15]. Other
Apicomplexan parasites such as Toxoplasma gondii and Cryptosporidium
parvum also have a single copy serca gene [16]. SERCA proteins are
evolutionary well conserved and are composed of three cytoplasmic
domains (A, actuator; N, nucleotide binding; P, phosphorylation),
ten transmembrane (M1–M10) helices constituting the transmem-
brane gate and small lumenal loops. Together the A, N and
P domains participate in regulating calcium binding and release
into the ER lumen. The whole molecule undergoes complex
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binding of two Ca2
+ and phosphorylation of the cytosolic head of
the molecule leading to conformational transitions opening the
transmembrane channel [11,17–18]. Thapisgargin, a highly cell-
penetrant sesquiterpene-lactone that once inside cells potently and
specifically inhibits mammalian SERCA, binds to a cavity at the
interface of the M3, M5 and M7 helices [19–20]. Importantly,
specific inhibition of SERCA by thapsigargin kills cancer cells by
provoking the apoptotic cell death pathway [21].
The sesquiterpene-lactone structure of thapsigargin, which is a
highly specific SERCA inhibitor, is structurally reminiscent of
artemisinin. Interestingly, both thapsigargin and artemisinin were
shown to inhibit the ATP hydrolysis activity of the PfSERCA
produced in the heterologous Xenopus laevis oocyte expression
system [9]. Consistent with the notion of PfSERCA inhibition,
thapsigargin antagonized the parasiticidal activity by artemisinins
[9]. In line with this, artemisinin-susceptibility of the PfSERCA
protein produced in the Xenopus laevis oocyst heterologous
expression system was abolished by introduction of a single
L263E point mutation [22]. Remarkably, a few years after the
introduction of artemether combination therapy in French
Guiana, a S769N PfSERCA polymorphism was observed in
several patient isolates presenting with a markedly increased 50%
Inhibitory Concentration (IC50) for arthemether and hence were
classified as in vitro-resistant [2–3]. However, this S769N
polymorphism was also reported in one African isolate, which
was susceptible to dihydroartemisinin in vitro [23]. It is worth
noting that artemisinin-resistant mutants of the murine malaria
parasite P. chabaudi chabaudi [24] or the related Apicomplexan
parasite T. gondii had an unaltered serca gene sequence though
calcium homeostasis was altered in these artemisinin-resistant T.
gondii parasites [25]. Thus, although the relationship between
Pfserca polymorphism and P. falciparum susceptibility to artemisinin
remains to be confirmed, it is conceivable that artemisinin-
resistance involves species-specific mechanisms, as shown for e.g.
chloroquine [26].
Insights into the relative impact of pfserca polymorphisms on the
biological function of the protein on the one hand and its
susceptibility to artemisinins on the other hand may be gained
from an analysis of field polymorphisms. Apart from the above
mentioned novel S769N mutation observed in French Guiana
[2–3] and Africa [23], a number of other pfserca polymorphisms
have been reported in laboratory lines [27] and in field isolates
from Africa [2,28–29], although their relationship with artemisinin
susceptibility remains unknown. An intriguing aspect is the
relatively large pfserca polymorphisms that they show relatively
large sequence diversity in comparison to other so-called house
keeping genes, such as the lactate dehydrogenase locus studied in
the same lines [27]. To further explore Pfserca sequence diversity
and to look for possible causes and geographical structuring, we
sequenced a large panel of field isolates from various malaria-
endemic geographic areas before widespread deployment of
ACT. Our data show clear evidence for geographic structuring
and indicate that as yet unknown evolutionary mechanisms are
contributing to the large field polymorphism of this locus in
some areas.
Results
Pfserca Polymorphism in the Field
We sequenced pfserca in 100 isolates collected from South
America, Asia and Africa (Table 1). Full length coding sequence
was determined for 56 isolates, and partial (positions 87-2862 of
the gene sequence) was obtained for 40 isolates. Overall, 29
codons carried one or more SNP. Codons 538, 569 and 987
harboured two mutations. A total of 32 distinct SNPs were
observed, of which 19 were non synonymous (NS) and 13
synonymous mutations, resulting in an average of one SNP/
115 bp (Table 2). 19 mutations had not been described previously.
Haplotype reconstruction allowed grouping samples into 28
distinct haplotypes/alleles (Table 3).
The predicted domain structure of PfSERCA based on
alignment of the reference PfSERCA protein sequence with other
sequences selected across the phylogenetic tree and the identified
functional and structural domains [30–35] (detailed in supple-
mentary Figures S1 and S2 with Supporting Information File #1)
is presented in Figure 1 A and B. As previously noted by other
authors [27,29], PfSERCA has the largest sequence of all those
deposited in NCBI as it contains specific inserts absent from all
other SERCAs. These inserts are mainly located in the N domain
facing the cytoplasmic side of the ER. The location of the various
SNPs observed in this panel of isolates is shown in Figure 1C.
Three SNPs were located within the A domain (codons 37, 89 and
141), all three were NS mutations. Twenty one SNPs were located
within the N-domain, 11 of which within the Plasmodium-specific
sequences (with 7 mutated codons –codons 569, 570, 621, 623,
630, 639 and 643 within a falciparum/reichenowi-specific insert). Of
the 21 SNPs affecting the N domain, only six were synonymous. In
contrast, seven of eight SNPs located in within the P-domain were
synonymous mutations, including two SNPs within a transmem-
brane domain. 3Five SNPs (R37K, W141G, S538S, S538R,
T539I) were located in the vicinity of residues essential for the
Table 1. Details of samples for which pfserca sequence was studied.
Continent Collection area No samples Year of collection Sequenced* Reference of sample collection
AFRICA Equatorial Guinea 9 2005–2006 Partial unpublished
Senegal 16 2003 Full-length Jambou et al., 2005
AMERICA Brazil (Amazonas) 10 2003–2006 Partial unpublished
Brazil (Para ´) 13 2005 partial Ferreira et al., 2007
French Guiana 20 2003 Full-length Jambou et al., 2005
ASIA Cambodia 24 2005 Full-length Jambou et al., 2005
Thailand 8 2002 partial Lopes et al., 2002
*gene region sequenced:
full-length refers to entire coding sequence, corresponding nucleotide 1-3687 (cordon 1-1228), partial refers to region encompassing nucleotide coordinates 87-2862 in
the Pfserca 3D7 reference sequence (PFA0310c).
doi:10.1371/journal.pone.0009424.t001
Polymorphism of Pf-SERCA
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amino acids described as of major importance for the SERCA
function in animal species (ATP, phosphate and Ca++ binding,
reviewed in [18]).
PfSERCA Polymorphism and Its Relationship with In Vitro
Susceptibility to Artemisinins
In the set of 100 patient isolates studied here, 60 had their in vitro
susceptibility profile assessed for an artemisinin derivative, either
artemether or artesunate [2]. Each of the isolates presenting an
IC50 greater than 20 nM had a distinct haplotype, but some
commonalities were observed. In French Guiana three isolates had
an IC50 for artemether greater than 100 nM; their haplotype was
[L402V N569S S769N I898I], [E431K 769N I898I], [L402V
S538S Q574P S769N I898I]. The haplotype of two isolates from
French Guiana with an IC50 for artemether in the 50–100 nM
range was [S538S S769N I898I] and [S569S I898I]. Five isolates
from French Guiana, which presented IC50 for artemether
between 20 and 50 nM had the following haplotype [S769N
I898I], [L402V S539R Q574P S769N I898I], [L402V S538R
I898I], [I898I], [D443D S769N I898I]. In Senegal there were
three isolates with an IC50 for artesunate between 20 and 45 nM,
their haplotypes were [E431K A623E], [E431K] and [L402V
A623E]. Of these mutations, only S769N, which was associated
with a high level of in vitro artemether resistance (IC50 above
30 nM) in French Guiana. S769N is located outside the falciparum-
specific insert, in a position close to the C-terminal hinge between
the N- and P- domains.
Table 2. List of the pfserca mutations detected.
Nucleotide
position
Codon
No
Wild-type
codon
Mutant
Codon
Aminoacid
(NS: bold; Syn: italics) Country of origin
110 37* AGA AAA R–K Brazil
266 89 ATA ACA I–T Thailand
421 141* TGG GGG W–V Senegal
1204 402 TTA GTA L–V Brazil French Guiana Senegal
1262 421** GGA GAA G–E French Guiana
1291 431** AGA AAA E–K Senegal
1323 441** TAT TAC Y–Y French Guiana
1329 443** GAT GAC D–D French Guiana
1395 465 AAT AAC N–N French Guiana
1612 538 AGT GGT S–R French Guiana
1614 538 AGT AGC S–S French Guiana
1616 539 ACC ATC T–I French Guiana
1671 557 TCT TCA S–S Equatorial Guinea
1706 569** AAT AGT N–S Equatorial Guinea
1707 569** AAT AAA N–K Equatorial Guinea
1710 570** ACA ACC T–T French Guiana
1721 574** ACA CCA Q–P French Guiana
1861 621** GCT TCT A–S French Guiana
1868 623** GCA GAA A–E Senegal
1888 630** GCT TCT A–S Brazil
1916 639** GGC GAC G–D Brazil
1927 643** GAA CAA E–Q Equatorial Guinea
2049 683 AAT AAG N–K Senegal
2306 769 AGT AAT S–N French Guiana
2656 885* ATT ATA I–I Senegal
2694 898* ATA AAT I–I Brazil French Guiana Equatorial Guinea
Senegal
2877 959 ATT ATA I–I Cambodia
2960 987 ATT CTT I–T Senegal
2962 987 ATT ATA I–I Cambodia
2974 998 AGT AGC S–S Senegal
3090 1030* AAG AAA K–K Cambodia
3093 1031* TGC TGT C–C Cambodia, Senegal
Legend: NS: non synonymous. Syn: synonymous. All nucleotide, codon and corresponding amino acid positions in the table are adjusted to correspond to positions in
the reference 3D7 sequence (accession n. PFA0310c) (http://www.plasmodb.org/plasmo/). Catalytic domains (*): cation atpase_N AA 3 – 81 and atpase_C, AA 1031–
1215, E1_E2 atpase AA 99 – 348/AA 358–364, hydrolase AA 790–935; Plasmodium specific area (**): AA 407–486, 569–671, 852–860.
doi:10.1371/journal.pone.0009424.t002
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S( gs)h H d K p DD * F *
French Guiana 9 (5) 12 0.889 2.084 0.00075 20.614
ns 21.203
ns 21.197
ns
Para ´ 4 (1) 3 0.564 1.538 0.00055 0.657
ns 0.335
ns 0.474
ns
Amazonas 2 (0) 3 0.689 0.822 0.00030 0.526
ns 1.026
ns 1.010
ns
Senegal 6 (2) 9 0.908 1.800 0.00065 20.016
ns 20.047
ns 20.044
ns
Eq. Guinea 5 (4) 6 0.889 1.444 0.00052 20.910
ns 21.239
ns 21.291
ns
Thailand 2 (1) 3 0.464 0.679 0.00024 20.448
ns 20.149
ns 20.238
ns
Cambodia 0 (0) 1 n.a. n.a. n.a. n.a. n.a. n.a.
America 13 (5) 15 0.818 1.998 0.00072 21.032
ns 20.943
ns 21.147
ns
Africa 10 (6) 13 0.910 1.727 0.00062 21.150
ns 21.654
ns 21.751
ns
Asia 2 (1) 3 0.140 0.209 0.00008 21.241
ns 20.714
ns 20.995
ns
All samples 21 (10) 28 0.742 1.500 0.00054 21.855* 22.501* 22.698*
Legend: The extent of pfserca gene sequence analysed here correspond to nucleotide coordinates 87-2862 of the PFA0310c pfserca sequence of the reference clone
3D7 (Plasmodium genome database PlasmoDB; http://www.plasmodb.org/plasmo/). N: sample size. S: number of segregating sites, of which the number of singletons
(gs) is presented in parenthesis. h: number of haplotypes. Hd: haplotype diversity (i.e. expected heterozygosity based on haplotype frequency). K: average number of
nucleotide differences between two sequences. p: average number of nucleotide differences between two sequences, per site. D: Tajima’s (1989) values for D-test. D*
and F* are Fu & Li’s (1993) values for the respective neutrality tests.
ns: not significant. *P,0.05. n.a.: not applicable (monomorphic).
doi:10.1371/journal.pone.0009424.t003
Figure 1. Predicted domains and localization of the mutations in Pf-SERCA protein sequence. A) Amino-Acid sequence of Pf-SERCA The
functional domains of the protein are located according to the alignment with the rabbit ATPase: A (boxed), P (box-grey) and N (underlined),
Plasmodium-specific domains are shown in italic. Hinge between P and N domains are bolded (TNQMT and DPPRK). Introns are located in the gene
after L1019 and K1119 (noted by the sign/). Transmembrane domains are bold-underlined. Mutations are boxed in grey (non-synonymous mutation
in bold). Three catalytic domains are predicted by PROSITE: cation atpase_N 3 – 81 and ATPase_C 1031–1215 (red), E1_E2 atpase 99 – 348/358-364
(blue), hydrolase 790–935 (braun). The position of the two introns is indicated with a/. B) Prediction of transmembrane domain by HMM (www.
PROSITE.org) Ten transmembrane domains were predicted using TMpred with ‘‘in to out’’ (i-o) or ‘‘out to in’’(o-i) orientation: M1 AA67-85 (o-i), M2
AA94-116 (i-o), M3 AA216-233 (o-i), M4 AA271-290 (i-o), M5 AA298-325 (o-i), M6 AA979-1005 (i-o), M7 AA1053-1073 (o-i), M8 AA1124-1140 (i-o), M9
AA1158-1175 (o-I), M10 AA1183-1206 (i-o). C) Schematic representation of the catalytic domains of Pf-SERCA and localization of the mutations.
Mutations are given symbols by continent of origin of the isolates (non synonymous mutations depicted with filled arrows, synonymous mutations
depicted with open arrows).
doi:10.1371/journal.pone.0009424.g001
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A total of 96 pfserca sequences were analysed for a fragment of
2785 bp encompassing nucleotides 87-2862. Nine positions
corresponding to tri-nucleotide microsatellite repeats (AAT)
starting at position 1292 were excluded from further analyses.
Thus, we analysed a partial fragment of 2776 bp, which corres-
ponded to nucleotide coordinates 87 – 2862 in the pfserca 3D7
reference sequence (accession n. PFA0310c) deposited at the
Plasmodium genome database PlasmoDB. Overall, 21 variable
sites were detected, of which 10 were singletons (positions 266,
421, 1262, 1329, 1612, 1671, 1707, 1710, 1868 and 1927) and 11
were parsimony informative (positions 110, 1204, 1291, 1614,
1706, 1721, 1888, 1916, 2049, 2306 and 2694). Of the 21
segregating sites, 5 were synonymous changes and 16 were non-
synonymous mutations (Table 2).
Parasites from Africa and America presented the highest
estimates of pfserca haplotype diversity, Hd (Table 3). Africa
showed comparable estimates of variability among samples (i.e.
countries) whereas in South America, the sample of French
Guiana was the only showing values of Hd comparable to Africa.
The two Brazilian samples had lower haplotype diversity, in
particular Amazonas’. A similar trend was observed in terms of
nucleotide diversity (Table 3), although in this case the South
American sample from Para ´ presented an estimate of p
intermediate to those obtained for African samples. Diversity for
the pfserca gene from Asia was very low. The sample from
Cambodia was monomorphic, while the sample from Thailand
displayed the lowest estimates of haplotype and nucleotide
diversities.
Tajima’s [36] and Fu & Li’s [37] (Table 3) tests showed no
significant departures from neutrality, either within country or
continents. Only when all sequences were pooled were significant
departures (P,0.05) observed in all tests, but this probably results
from ascertainment bias due to sampling of a non-randomly
mating gene pool. The dN/dS ratios were below one, indicative of
purifying selection, except for the sample of Amazonas in which no
synonymous mutations were detected (Table 4). However,
differences between dN and dS were non-significant in all samples.
For the McDonald-Kreitman test, marginally significant (P,0.05)
departures from neutrality associated with NI values above one
(indicative of purifying selection) were detected in the samples of
French Guiana and Senegal (Table 4). These tests were not
considered significant after applying Bonferroni corrections for
multiple tests (adjusted significance level: a’=0.009).
Overall, genetic differentiation of pfserca (global FST=0.214,
P,0.001) reflected the geographic origin of samples. Highly
significant FST estimates (P,0.001) were obtained for the three
pair wise comparisons: America vs. Africa (FST=0.097), America
vs. Asia (FST=0.088), Africa vs. Asia (FST=0.117). In Asia, all
comparisons involving the monomorphic sample of Cambodia
were significant, with the exception of the neighbour sample from
Thailand (Table 5). In Africa, no significant genetic differentiation
was observed between the two samples of this continent,
(FST=0.066). In contrast, American samples showed high pair
wise FST values, particularly in comparisons involving Amazonas,
which supports a high P. falciparum population subdivision in this
area.
To analyse this geographic subdivision, a genealogical network
was produced using the TCS software with correction of the
reticulations [38] (Figure 2). The ancestral haplotype (A1) was
present in all samples and it was the predominant haplotype in the
Asian ones. The second most represented haplotype (A2) was
present only in Africa and Asia. All remaining haplotypes were
region or country-specific. Samples from French Guiana revealed
a complex genealogical pattern derived from A1 and formed by
unique branches separated from A1 by up to six mutational steps
with low-frequency internal clades.
Discussion
The large sequence diversity observed in this analysis confirms
findings from previous pfserca molecular surveys. For instance, in
Niger six different mutations were found [28] while Dahlstrom et
al. [29] found 31 mutations in 302 samples from Zanzibar and
three mutations in 39 Tanzanian samples. Similarly Menegon et al.
[39] found seven mutations in 71 specimens. The synthesis of all
reported polymorphisms is provided in Table S1 (with Figure -
References S1). The overall degree of pfserca polymorphism in our
study was one SNP/115 bp and when including all published
sequences (some of which being quite partial) this figure was one
SNP/55 bp. This somehow puts pfserca at odds compared to genes
Table 4. dN/dS ratio and McDonald-Kreitman test of neutrality for the pfserca gene.
dN/dS ratio McDonald-Kreitman test
Interspecific fixed
nucleotide differences
Intraspecific nucleotide
polymorphisms
dN/dS P-value
1 Syn Nsyn Syn Nsyn NI P-value
2
French Guiana 0.53 0.511 43 15 3 6 5.7 0.022
Para ´ 0.59 0.707 43 15 1 3 8.6 0.070
Amazonas ‘ 0.169 43 15 0 2 n.a. 0.077
Senegal 0.75 0.824 43 15 1 5 14.3 0.010
Eq. Guinea 0.22 0.318 43 15 2 3 4.3 0.136
Thailand 0.15 0.415 43 15 1 1 2.9 0.475
Cambodia n.a. n.a. 43 15 0 0 n.c. n.c.
Legend P-value
1: two-tailed Z-test based on 1000 bootstraps with an alternative hypothesis of dN?dS. Syn: synonymous. Nsyn: non-synonymous. NI: neutrality index. P-
value
2: P-value of Fisher’s Exact test. ‘: infinite (no synonymous polymorphisms). n.a.: not applicable (no intraspecific synonymous polymorphisms). n.c.: not computed
(monomorphic sample).
The extent of pfserca gene sequence analysed here correspond to nucleotide coordinates 87-2862 of the PFA0310c pfserca sequence of the reference clone 3D7
(Plasmodium genome database PlasmoDB; http://www.plasmodb.org/plasmo/).
doi:10.1371/journal.pone.0009424.t004
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much higher than estimated average of one SNP/910 bp in
coding regions [40], one common SNP per 842 bp [41], one
SNP/780 bp across three fully sequenced genomes and one every
446 bases across certain large genomic regions [42]. Considering
that intronic sequences that evolve more rapidly than coding
sequences were excluded from our analysis, our SNP rates are if
anything going to have been underestimated. Kidgell et al
reported that genes located in the central regions of chromosomes
(as is pfserca) usually present minimal sequence diversity [43].
Interestingly however, as noted in chromosome or genome wide
studies [41–42] most SNP were rare, with 15 SNPs observed once
and only 6 SNPs presenting a.5% frequency in the samples
analysed. As a result, in the set of samples studied, a minority of
SNPs (3 of 32) were observed in multiple settings, and a similar
conclusion can be drawn when analysing the compiled list of SNPs
reported to date, with only 14 of 68 mutations observed in multiple
settings.
Parasites from Africa and America were the most genetically
diverse. Within the African continent samples showed comparable
estimates of variability among the different countries sampled.
Samples from Asia presented the lowest genetic diversity. These
observations are in line with a previous report indicating reduced
diversity in Asian P. falciparum parasites inferred by typing of 183
SNPs across chromosome 3 [40], but contrast with other studies
showing lower genetic diversity in South America than in Asia
[44–46]. For instance, Mehlotra et al report a much lower Pfcrt
and Pfmdr haplotype diversity in samples from South America,
including Brazil and Guyana – which borders French Guiana-
compared to parasites from African areas [45], contrasting with
our observation of similar, large diversity in Africa and South
America for pfserca. Neafsey et al studied a large panel of SNPs
across the 14 chromosomes in a set of isolates including isolates
from Brazil, Senegal and Thailand –three geographic areas
sampled here as well- and found that the lowest diversity was in
Brazil [46]. In our study, the lowest diversity of the three areas was
Thailand. The reason of our discrepancy with the latter studies is
unclear but this may be due to differences in technical approach
used to study polymorphism or differences in sampling or in the
genomic regions analysed, since the degree of genetic differenti-
ation in P. falciparum has been shown to vary across the genome.
Moreover we did not include the non coding regions in our
analysis and did not survey intronic or flanking 59 or 39
microsatellite diversity, known to be much larger than coding
sequences.
Importantly, genetic differentiation at the pfserca gene reflected
the geographic origin of samples. When samples were pooled by
continent, highly significant (P,0.001) FST estimates were obtained
for the three pair wise comparisons (0.088#FST#0.117). This is
in line with numerous studies of chromosomal or mitochondrial
genes [40–43,46]. Within continents, the monomorphic sample of
Cambodiawasnot significantly differentfromthe neighboursample
from Thailand, and virtually no population substructure was
observed in Africa. In contrast, samples from the American
continent showed significantly high pair wise FST values, particu-
larly in comparisons involving the sample from Amazonas. This
suggests a much higher P. falciparum population substructure is
detected by this gene in South America, a conclusion in agreement
with the notion of a higher P. falciparum population differentiation in
regions of lower malaria transmission [44]. Interestingly, estimates
of genetic variation in America were greatly influenced by the
FrenchGuiana cohort, in which diversity was comparable to Africa.
Thismay be due to the particular micro-epidemiological scenario in
French Guiana, with patchy foci, each with a small number of
inhabitants having easy access to antimalarial drugs, a situation that
favours outgrowth of variant parasites. This was further confirmed
by a genealogy displaying multiple tip haplotypes suggesting a local
recent expansion of pfserca diversity. The peculiar epidemiology of
the French Guiana area was also outlined by a previous study of the
mitochondrial cytb gene, which displayed a particularly elevated
polymorphism with specific SNPs, some reaching very high
frequency [47].
In the TCS genealogical network, the most frequent haplotype
was represented in samples from all continents surveyed and it is
also likely to be the ancestral haplotype of pfserca. No clear
overrepresentation of samples from a particular continent
occurred within this haplotype and all internal haplotypes
originating from the ancestor were distributed equally between
South America and Africa. The network revealed a high number
of low frequency external clades, which may be indicative that the
gene is evolving rapidly. The particular reasons why this happens
are difficult to disentangle from epidemiological or gene-specific
function scenarios. Pfserca is the only serca gene of Plasmodium,
making it highly specialized and unique for the parasite’s calcium
homeostasis. Interestingly, it has been recently suggested that
highly specialized genes in the Plasmodium genome are more likely
to undergo accelerated selective processes [48–49]. However,
neither Tajima’s nor Fu & Li’s tests provided evidence of
departures from neutrality and calculations of the McDonald-
Kreitman test identified only marginally significant departures in
French Guiana (P=0.022) and in Senegal (P=0.010). These were
associated with NI values .1 indicative of purifying selection.
Although the P-values were not considered significant after
Bonferroni corrections for multiple tests, it was interesting to
Table 5. Genetic differentiation between samples, measured by FST.
French Guiana Para ´ Amazonas Senegal Equatorial Guinea Thailand
French Guiana -
Para ´ 0.213 -
Amazonas 0.308 0.341 -
Senegal 0.179 0.136 0.336 -
Equato Guinea 0.190 0.077 0.367 0.066 -
Thailand 0.175 0.092 0.412 0.078 20.019 -
Cambodia 0.198 0.231 0.543 0.200 0.188 0.095
Legend: Underlined: P,0.05; In bold: significant estimate after Bonferroni correction. The extent of pfserca gene sequence analysed here correspond to nucleotide
coordinates 87-2862 of the PFA0310c pfserca sequence of the reference clone 3D7 (Plasmodium genome database PlasmoDB; http://www.plasmodb.org/plasmo/).
doi:10.1371/journal.pone.0009424.t005
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susceptibility of P. falciparum to an artemisinin derivative was
reported at the time of sample collection [2]. Purifying selection
acts to prevent divergence of structure and function by selecting
against extreme values of a trait, in contrast to directional
selection, where a single phenotype is selected and therefore allele
frequency shifts in one direction. The latter type of natural
selection is more likely to occur on drug resistant determinants but
probably does not apply for the present set of samples collected
before substantial artemisinin pressure was in place in all the areas
surveyed. Furthermore, the two most frequent SNPs were
synonymous and their frequency varied greatly with the area/
continent surveyed. The I898I mutation reached very high local
frequency in Asia (0.78 in Cambodia, 0.85 in Thailand), but also
in other areas such as Brazil (local frequency 0.85) or Equatorial
Guinea (local frequency 0.50), while they were not detected at all
in Senegal or French Guiana. Although we cannot exclude that
such synonymous mutations may not be phenotypically silent as
some synonymous mdr mutations were shown to influence the rate
of translation, protein folding and substrate specificity [50], we
tentatively conclude that it is likely that neutral evolution operating
on possible multiple colonising events is currently shaping
polymorphism at the pfserca gene of P. falciparum at this stage in
history i.e. before massive worldwide deployment of artemisinin
derivatives. Multiple colonisation events by ancestral parasites
spreading out of Africa to the other continents have been
suggested by the analysis of mitochondrial DNA [51].
The most obvious and statistically significant association
regarding artemisinin susceptibility was that of the 769N mutation
with an increased IC50 for artemether [2]. This was only observed
Figure 2. TCS network for the pfserca gene of Plasmodium falciparum. Each distinct haplotype is represented by an oval with size
proportional to its frequency (in parenthesis). Mutational steps are represented by lines. Dots connecting lines represent putative haplotypes that
were not sampled. Dashed lines refer to reticulations corrected according to Crandall et al. [38]. Colours correspond to each continent sampled: blue-
America (AM: Amazonas; FG: French Guiana; PA: Para), green - Africa (EQ: Equatorial Guinea; SE: Senegal), red - Asia (CA: Cambodia; TH: Thailand).
doi:10.1371/journal.pone.0009424.g002
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in the vicinity of the predicted hinge domain of the protein, which
influences binding of the calcium ion. As the inhibitory effect of
thapsigargin depends on the engagement of the first calcium ion in
the binding site [17,30,52,53], it is possible that the 769N
mutation decreases the capacity of artemisinin to impair this
process. This mutation was not detected in Asia and in the vast
majority of African isolates studied so far [28–29], except in one
dihydroartemisinin-susceptible isolate whose in vitro susceptibility
to artemether remains unknown [23]. The marked geographical
clustering of isolates from Asia, Africa and America observed here
may account for the particular artemether resistance/pfserca
mutations relationship found in America, especially as high levels
of in vitro resistance to artemether have only been observed in
America so far and as the genetic background of parasites from
South America differs from Asia or Africa [40–44,46]. The
association of 769N with artemether susceptibility and its
relationship to the in vitro susceptibility to dihydroartemisinin
certainly needs to be further studied. To ascertain the functional
role of this mutation, biochemical studies with the mutant enzyme
are needed along with genetic exchange studies in P. falciparum
parasites. It is however possible that some mutations such as 769N
have a heavy fitness cost, as parasites harbouring the mutation
could not be propagated in vitro under standard culture conditions.
An important question for future studies is whether or not pfserca
genetic characteristics change over time and in particular under
the pressure by artemisinin derivatives delivered as combination
therapies. In this regard, a recent survey of haplotype diversity for
two chloroquine resistance candidate genes, pfcrt and pfmdr1,
provides important clues for interpreting genetic variation of drug
resistance candidate genes in light of drug pressure. This study
showed that overall genetic variation in the pfcrt gene was lower
than in the pfmdr1 gene because chloroquine has exerted a stronger
selective pressure on pfcrt favouring the occurrence of selective
sweeps around the locus, resulting in reduced genetic diversity
with time [45]. Because pfmdr1 is a putative modulator of responses
to artemisinin combination therapies as well as of chloroquine,
future patterns of pfmdr1 variation may help understand the
specific selective pressures of the newly implemented combination
therapy policy. The present data will serve as a useful snapshot to
infer how pfserca polymorphisms is affected by drug pressure and
whether some SNPs/haplotypes are selected by artemisinin
combination therapies.
The significance of the large pfserca polymorphism and the
consequences of the mutations described here on the protein’s
function and regulation are unclear. As indicated above, the
dominant allele in all settings was the 3D7-type supposedly coding
for a wild type sequence. In Cambodia, all mutations were
synonymous, and likewise all but one sample from Thailand had
only synonymous SNPs. This suggests substantial functional
constraints. In line with the bioinformatic modelling [35]
alignment of the PfSERCA sequence with other proteins outlined
high conservation of all functional domains and transmembrane
helices of the protein. PfSERCA is the largest SERCA described
so far due to the presence of large falciparum-specific inserts most of
which map to a region of the extra-membranous head that in
other SERCAs is associated with closing the calcium channel. This
suggests that these inserts could influence the channels properties
by altering the conformational changes associated with calcium
transport, and/or cope with specific requirements associated with
intracellular calcium homeostasis in the human erythrocyte or
hepatocyte host cell. As artemisinin was shown to inhibit T. gondii
SERCA and trigger calcium release [54], the link between
PfSERCA and calcium homeostasis deserves detailed investiga-
tion. This could furthermore offer new insights on factors possibly
contributing to the high level of polymorphism of PfSERCA.
Interestingly, the areas where the highest PfSERCA diversity was
observed in this work and in previous studies are those with an
elevated prevalence of haemoglobinopathies such as HbS, namely
African populations [55] and South American countries with a
substantial population of African origin (e.g. Belize, French
Guiana and north Brazil). Sickle cell anaemia and beta-
thalassaemia are associated with an elevation of total red cell
calcium content [56–59]. This abnormally high cytosolic calcium
content could be a selective force for mutant PfSERCA as an
enhanced activity of this pump is needed in such environments to
restore physiological intracellular calcium stores [60–61]. This
possibility is currently under investigation.
Materials and Methods
For more details see also Materials and Methods S1.
Ethics Statement
This program received ethical clearance from all the National
Ethical Committees of the countries involved in the study (NEC of
Senegal, Cambodia, Brazil, Thailand, and the CCPRB of French
Guiana). All the patients enrolled (or their family) gave a written
informed consent for the protocol.
Sample Collection
Blood samples were obtained from consenting patients attend-
ing dispensaries with uncomplicated P. falciparum malaria (Table 1).
The following isolates were used as characteristic haplotypes: F126
(GU456693), F128 (GU456694), F119 (GU456695), F91 (GU-
456696), F94 (GU456697), F64 (GU456698), F139 (GU456699),
F132 (GU456700), F122 (GU456701), F108 (GU456702), F41
(GU456703), AM54 (GU456704), AM46 (GU456705), BR67 (GU-
456706), 8A (GU456707), 66A (GU456708), 22A (GU456709),
22G (GU456710), 24G (GU456711), 7A (GU456712), 58A (GU-
456713), 80A (GU456714), 9A (GU456715), EQG66 (GU456716),
EQG41 (GU456717), EQG72 (GU456718), EQG28 (GU456719),
RC17 (GU456720).
Sequencing of Field Isolates
Parasite DNA was extracted from red blood cells by standard
phenol/chloroform method. Primers used were synthesized based
on the published sequence of Pfatp6 (Genbank, AN AJ532679).
Samples from Thailand, Equatorial Guinea, Brazil 5amazonas
and Para `) were sequenced as described [62]. Samples from French
Guiana, Senegal and Cambodia were amplified using the
following primers pairs (numbering refers to indicates the position
of the first nucleotide of the primer in the PFA0310c sequence): 20
59ATGCTCATACATACGATGTTGAG/1607 59 AATATGA-
ACAGTGATCCTCAGAC; 1268 59 TTGAAGCTTTAACG-
GATGATGGA/3039 59 TACCTAGTGCTGTTGCTGGTAA;
3207 59 AATCCACCAGAACATGACGTAAT/3457 59AATA-
TGAACAGTGATCCTCAGAC; 3335 59 TAGGCAAGCAC-
CTTATCTTTATC/3952 59 TTTTCTTGGTTCTTTGCTC-
TTCC. PCR reactions were done in 50 mL in the presence of
2.5 mM MgCl2, 2.5 U AmpliTaq Gold (Applied Biosystems). An
initial denaturation at 94uC for 9 min, was followed by 38 cycles at
94uC for 1 min, 60uC for 2.5 min (for primers 20/1607 and 1268/
3039, and 3 min at 56uC for primers 3207/3457 and 3335/3952)
72uC for 2 min followed by one cycle were the last elongation was
for 10 min. PCR products were sequenced on both strands using
internal primers essentially as described [47]. Potential sequence
ambiguities were resolved either by re-sequencing or through close
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(www.phrap.org).
Bioinformatic Analysis
Sequences have been aligned using CLUSTALX software
(version1.81) [63] and BOXSHADE (www.pasteur.fr). Functional
areas were predicted using PROSITE. Prediction of the PfSERCA
domains was performed by alignment with a set of other
eukaryotic serca (P. yoelii, P. gallinaceum, P. knowlesi, P. berghei, P.
reichenowi, P. vivax, Oryctolagus cuniculus, Homo sapiens, Mus musculus,
Rattus norvegicus, Caenorhabditis elegans, Leishmania donovani, Trypano-
soma cruzi). Helix prediction was performed using TMpred
software (www.expasy.ch).
Phylogenetic Analysis of the Coding Sequence
Sequence polymorphism analysis and neutrality tests were
performed using the software DnaSP 4.50.3 [64]. Neutrality was
tested using Tajima’s [36] and Fu & Li’s [37] tests. Departures from
selective neutrality at the protein level were assessed by the dN/dS
ratio and the McDonald-Kreitman test. For between-species
comparisons, a sequence of the ATPase6 gene from the closely
related P. reichenowi (GenBank nu AB122148.1) was used. For dN/dS
ratios, significance was determined by a two-tailed Z-test available
in MEGA 4.0.2 [65]. Fisher’s exact tests on 262 contingency tables
were used for McDonald-Kreitman tests, as implemented in
DnaSP [66].
Levels of genetic differentiation were measured by the fixation
index FST, based on nucleotide frequency differences [64]. To
assess if FST values significantly differed from zero, permutation
tests were performed based on the KST* estimator of pair wise
nucleotide differences [64]. Calculations were performed with
DnaSP. A genealogical network was produced using the TCS
software [67], with correction of the reticulations following
Crandall and Templeton [38].
Whenever multiple tests were performed, the nominal signifi-
cance level (a=0.05) was adjusted by Bonferroni corrections to
avoid type I error (i.e. false rejection).
Supporting Information
Figure S1 Mapping of the three main domains in Pf-SERCA
Legend Three major motifs were detected using PROSITE: A)
pfam00122.11 (E1-E2 ATPase) (residues 107-357 of PfSERCA); B)
pfam00689.11 (Cation_ATPase_C) (residues 1032-1215 of
PfSERCA), and C) pfam00702.11 (Hydrolase) (residues 790-931
of PfSERCA). Domains are mapped with sequences characteristic
of the functions (indicated by accession number). In red conserved
amino acid of the motifs.
Found at: doi:10.1371/journal.pone.0009424.s001 (0.47 MB PPT)
Figure S2 Alignment of Pf-SERCA with other known SERCA to
point out amino acids of interest in the falciparum protein.
Alignment of the SERCA protein sequences from five Plasmodium
species with ten sequences selected across the phylogenetic tree.
PfSERCA has the largest sequence of all those deposited in NCBI.
The global SERCA structure is easily identifiable, with a cytosolic
head composed of three domains homologous to the rabbit A, P,
and N domains. Note that the PfSERCA and the P.reichenowi
SERCA sequence contain specific inserts absent from all other
SERCAs. These inserts, mainly located in the N domain located on
the cytoplasmic side of the ER contain no identifiable motif. The
region was predicted to be part of the extra-membranous head
responsible for closing the Ca++ channel during the E1-E2
conformational change. The integral membrane domain of the
protein is composed of ten helix domains, in line with other
SERCAs. The two calcium pockets are completely conserved with
only a shift in the position in the sequence due to a larger head. The
key P-phosphorylation residue [1] was predicted to be D357, in line
with the analysis of Nagamune et al [2]. In other SERCAs,
phosphorylation of this aspartate in the presence of calcium induces
a major conformational E1-E2 transition in the enzyme, associated
with the release of the cation into the luminal side of the membrane
(reviewed in [3]). This movement involves two well conserved
hinges [4–6] that are also present in PfSERCA: i) at the interface of
N and A domains (motif 601DPPRK in rabbit SERCA,
corresponding to motif 798DPPRK in PfSERCA), and ii) between
N and P domains (308TNQM in rabbit, 405TNDI in PfSERCA).
Along the same line, C674 recently identified as a key residue in the
NO-induced glutathione regulation of the rabbit SERCA, was
identified as C887 in the PfSERCA sequence [7–8]. The
thapsigargin binding site involving (F256-I765-Y837) in the human
SERCA can putatively be located in the PfSERCA (F264-I976-
Y1048, Figure S2), and is juxtaposed to the putative artemisinin site
(L263, I272, F273, I1041) as proposed by in silico docking after
deleting falciparum-specific inserts [9]. Three major domains are
mapped: A domain (in blue), N domain (in green), P domain (in
red). Conserved amino acids are bolded. Three numbering of
amino acids are shown, P.falciparum, rabbit and human.
Found at: doi:10.1371/journal.pone.0009424.s002 (0.42 MB
XLS)
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0009424.s003 (0.04 MB
DOC)
Table S1
Found at: doi:10.1371/journal.pone.0009424.s004 (0.14 MB
PDF)
References S1
Found at: doi:10.1371/journal.pone.0009424.s005 (0.00 MB
RTF)
Acknowledgments
We thank all the medical staff of the Health centres for their technical
support and collection of clinical data: i) Senegal: Guediawaye (conducted
by Alioune Gaye), St Martin (conducted by Sr Marie-Madeleine), ii)
Amazonas: councils of Autazes, Barcelos, Borba, Careiro, Coari, Guajara ´,
Humaita ´, Itacoatiara, Manaus, Presidente Figueiredo, Sa ˜o Gabriel da
Cachoeira and Tefe ´. We also thank Mariano Zalis, Mo ˆnica R. Costa and
Laila C.A.Rojas for technical support. We are grateful to Prof. Virgı ´lio E.
do Rosa ´rio for providing logistical support and encouraging this work.
Author Contributions
Conceived and designed the experiments: RJ. Performed the experiments:
RJ AM JP EL MN NK LP BV MTE CB TF PB AB IDF CF MGA.
Analyzed the data: RJ AM SG MN PC. Contributed reagents/materials/
analysis tools: AM JP EL LP TF PB AB IDF CF PPV MGA. Wrote the
paper: RJ OMP PC.
References
1. World Malaria Report (2008) WHO. www.who.int.
2. Jambou R, Legrand E, Niang M, Khim N, Lim P, et al. (2005) Resistance of
Plasmodium falciparum field isolates to in-vitro artemether and point mutations
of the SERCA-type PfATPase6. Lancet 366: 1960–1963.
3. Legrand E, Volney B, Meynard JB, Esterre P, Mercereau-Puijalon O (2007)
Resistance to Dihydroartemisinin. Emerging Infectious Diseases 13: 808–9.
4. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008)
Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium Evidence
Polymorphism of Pf-SERCA
PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e9424of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359:
2619–20.
5. Lim P, Alker AP, Khim N, Shah NK, Incardona S, et al. (2009) Pfmdr1 copy
number and arteminisin derivatives combination therapy failure in falciparum
malaria in Cambodia. Malar J 8: 11.
6. Rogers WO, Sem R, Tero T, Chim P, Lim P, et al. (2009) Failure of artesunate-
mefloquine combination therapy for uncomplicated Plasmodium falciparum
malaria in southern Cambodia. Malar J 8: 10.
7. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, et al. (2009)
Changes in the treatment responses to artesunate-mefloquine on the
northwestern border of Thailand during 13 years of continuous deployment.
PLoS ONE 4: e4551.
8. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, et al. (2009)
The last man standing is the most resistant: eliminating artemisinin-resistant
malaria in Cambodia. Malar J 8: 31.
9. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, et al. (2003)
Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957–61.
10. Krishna S, Woodrow CJ, Staines HM, Haynes RK, Mercereau-Puijalon O
(2006) Re-evaluation of how artemisinins work in light of emerging evidence of
in vitro resistance. Trends in Molecular Medicine 12: 200–5.
11. Toyoshima C, Inesi G (2004) Structural basis of ion pumping by Ca2+-ATPase
of the sarcoplasmic reticulum. Annu Rev Biochem 73: 269–92.
12. Toyoshima C (2009) How Ca(2+)-ATPase pumps ions across the sarcoplasmic
reticulum membrane. Biochim Biophys Acta 1793: 941–6.
13. Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of
calcium signaling. Nat Rev Mol Cell Biol 1: 11–21.
14. Wuytack F, Raeymaekers L, Missiaen L (2002) Molecular physiology of the
SERCA and SPCA pumps. Cell Calcium 32: 279–305.
15. Kimura M, Yamaguchi Y, Takada S, Tanabe K (1993) Cloning of a Ca(2+)-
ATPase gene of Plasmodium falciparum and comparison with vertebrate
Ca(2+)-ATPases. J Cell Sci 104: 1129–36.
16. Nagamune K, Sibley LD (2006) Comparative genomic and phylogenetic
analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa.
Mol Biol Evol 23: 1613–27.
17. Toyoshima C, Nomura H, Sugita Y (2003) Structural basis of ion pumping by
Ca
2+-ATPase of sarcoplasmic reticulum. FEBS Letters 555: 106–10.
18. Toyoshima C (2008) Structural aspects of ion pumping by Ca2+-ATPase of
sarcoplasmic reticulum. Arch Biochem Biophys 476: 3–11.
19. Xu C, Ma H, Inesi G, Al-Shawi MK, Toyoshima C (2004) Specific structural
requirements for the inhibitory effect of Thapsigargin on CA++ATPase SERCA.
J Biol Chem 279: 17973–9.
20. Inesi G, Lewis D, Ma H, Prasad A, Toyoshima C (2006) Concerted
conformational effects of Ca2+ and ATP are required for activation of
sequential reactions in the Ca2+ ATPase (SERCA) catalytic cycle. Biochemistry
45: 13769–78.
21. Christensen SB, Skytte DM, Denmeade SR, Dionne C, Møller JV, et al. (2009)
A Trojan horse in drug development: targeting of thapsigargins towards prostate
cancer cells. Anticancer Agents Med Chem 9: 276–94.
22. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, et al.
(2005) A single amino acid residue can determine the sensitivity of SERCAs to
artemisinins. Nat Struct Mol Biol 12: 628–9.
23. Cojean S, Hubert V, Le Bras J, Durand R (2006) Resistance to dihydroarte-
misinin. Emerg Infect Dis 12: 1798–9.
24. Afonso A, Hunt P, Cheesman S, Alves A, Cravo P (2006) Malaria parasites can
develop stable resistance to artemisinin but lack mutations in candidate gene
ATPase 6, tctp, mdr1 and cg10. Antimicrob Agents Chemother 50: 480–489.
25. Nagamune K, Beatty WL, Sibley LD (2007) Artemisinin induces calcium-
dependent protein secretion in the protozoan parasite Toxoplasma gondii.
Eukaryot Cell 6: 2147–56.
26. Hunt P, Cravo PV, Donleavy P, Carlton JM, Walliker D (2004) Chloroquine
resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt)
and multi-drug resistance (mdr1) orthologues involved? Mol Biochem Parasitol
133: 27–35.
27. Tanabe K, Sakihama N, Hattori T, Ranford-Cartwright L, Goldman I, et al.
(2004) Genetic distance in housekeeping genes between Plasmodium falciparum
and Plasmodium reichenowi and within P. falciparum. J Mol Evol 59: 687–94.
28. Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB (2009) Polymorphism
of PfATPase in Niger: detection of three new point mutations. Malar J 8: 28.
29. Dahlstro ¨m S, Veiga MI, Ferreira P, Ma ˚rtensson A, Kaneko A, et al. (2008)
Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of
Plasmodium falciparum (PfATP6). Infect Genet Evol 8: 340–5.
30. Ma H, Lewis D, Xu C, Inesi G, Toyoshima C (2005) Functional and structural
roles of critical amino acids within the‘‘N’’, ‘‘P’’, and ‘‘A’’ domains of the Ca2+
ATPase (SERCA) headpiece. Biochemistry 44: 8090–100.
31. Toyoshima C, Nomura H (2002) Structural changes in the calcium pump
accompanying the dissociation of calcium. Nature 418: 605–11.
32. Montigny C, Picard M, Lenoir G, Gauron C, Toyoshima C, et al. (2007)
Inhibitors bound to Ca(2+)-free sarcoplasmic reticulum Ca(2+)-ATPase lock its
transmembrane region but not necessarily its cytosolic region, revealing the
flexibility of the loops connecting transmembrane and cytosolic domains.
Biochemistry 46: 15162–74.
33. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, et al. (2004) S-
Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by
nitric oxide. Nat Med 10: 1200–7.
34. Cohen RA, Adachi T (2006) Nitric-Oxide-Induced Vasodilatation: Regulation
by Physiologic S-Glutathiolation and Pathologic Oxidation of the Sarcoplasmic
Endoplasmic Reticulum Calcium ATPase. Trends Cardiovasc Med 16:
109–114.
35. Jung M, Kim H, Nam KY, No KT (2005) Three-dimensional structure of
Plasmodium falciparum Ca2+ -ATPase(PfATP6) and docking of artemisinin
derivatives to PfATP6. Bioorg Med Chem Lett 15: 2994–2997.
36. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by
DNA polymorphism. Genetics 123: 585–595.
37. Fu YX, Li WH (1993) Statistical tests of neutrality of mutations. Genetics 133:
693–709.
38. Crandall KA, Templeton AR (1993) Empirical tests of some predictions from
coalescent theory with applications to intraspecific phylogeny reconstruction.
Genetics 134: 959–969.
39. Menegon M, Sannela AR, Majori G, Severini C (2008) Detection of novel point
mutation in the Plasmodium falciparum ATPase candidate gene for resistance to
artemisinin. Parasitol Int 57: 233–235.
40. Mu J, Awadalla P, Duan J, McGee KM, Joy DA, et al. (2005) Recombination
hotspots and population structure in Plasmodium falciparum. PLoS Biol 3: e335.
41. Mu J, Awadalla P, Duan J, McGee KM, Keebler J, et al. (2007) Genome-wide
variation and identification of vaccine targets in the Plasmodium falciparum
genome. Nat Genet 39: 126–130.
42. Volkman SK, Sabeti PC, DeCaprio D, Neafsey DE, Schaffner SF, et al. (2007) A
genomewide map of diversity in Plasmodium falciparum. Nat Genet 39: 113–119.
43. Kidgell C, Volkman SK, Daily J, Borevitz JO, Plouffe D, et al. (2006) A
systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog 2: e57.
44. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, et al.
(2001) Microsatellite markers reveal a spectrum of population structures in the
malaria parasite Plasmodium falciparum. Mol Biol Evol 17: 1467–82.
45. Mehlotra RK, Mattera G, Bockarie MJ, Maguire JD, Baird JK, et al. (2008)
Discordant patterns of genetic variation at two chloroquine resistance loci in
worldwide populations of the malaria parasite Plasmodium falciparum.
Antimicrob Agents Chemother 52: 2212–22.
46. Neafsey DE, Schaffner SF, Volkman SK, Park D, Montgomery P, et al. (2008)
Genome-wide SNP genotyping highlights the role of natural selection in
Plasmodium falciparum population divergence. Genome Biol 9: R171.
47. Ekala MT, Khim N, Legrand E, Randrianarivelojosia M, Jambou R, et al.
(2007) Sequence analysis of Plasmodium falciparum cytochrome b in multiple
geographic sites. Malar J 6: 164.
48. Gardner MJ, Tettelin H, Carucci DJ, Cummings LM, Aravind L, et al. (1998)
Chromosome 2 sequence of the human malaria parasite Plasmodium
falciparum. Science 282: 1126–32.
49. Jeffares DC, Pain A, Berry A, Cox AV, Stalker J, et al. (2007) Genome variation
and evolution of the malaria parasite Plasmodium falciparum. Nat Genet 39:
120–5.
50. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, et al. (2007) A
‘‘silent’’ polymorphism in the MDR1 gene changes substrate specificity. Science
315: 525–8.
51. Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, et al. (2003) Early origin and
recent expansion of Plasmodium falciparum. Science 300: 318–21.
52. Toshihiko T, Kurzydlowski K, Lyttonll J, MacLennan DH (1992) The
Nucleotide Binding/Hinge DomainP lays a Crucial Role in Determining
Isoform-specific Ca29 dependence of Organellar Ca29-ATPases. J Biol Chem
267: 14490–14436.
53. Yu M, Lin J, Khadeer M, Yeh Y, Inesi G, Hussain A (1999) Effects of various
amino acid 256 mutations on sarcoplasmic/endoplasmic reticulum Ca2+
ATPase function and their role in the cellular adaptive response to thapsigargin.
Arch Biochem Biophys 362: 225–32.
54. Nagamune K, Moreno SN, Sibley LD (2007) Artemisinin-resistant mutants of
Toxoplasma gondii have altered calcium homeostasis. Antimicrob Agents
Chemother 51: 3816–23.
55. Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and
derived service indicators. WHO bulletin 86: 480–487.
56. Hebbel RP, Steinberg MH, Eaton JW (1981) Erythrocyte calcium abnormalities
in sickle cell disease. Prog Clin Biol Res 51: 321–32.
57. Mentzer WC, Clark MR (1983) Disorders of erythrocyte cation permeability
and water content associated with hemolytic anemia. Biomembranes 11:
79–118.
58. Wu SN (2003) Large-conductance Ca2+- activated K+ channels:physiological
role and pharmacology. Curr Med Chem 10: 649–61.
59. Fo ¨ller M, Huber SM, Lang F (2008) Erythrocyte programmed cell death.
IUBMB Life 60: 661–8.
60. Kawazoe U, Fang J, Miranda S, de Souza W, Plattner H, et al. (2008)
Acidocalcisomes in Apicomplexan parasites. Experimental Parasitology 118:
2–9.
61. Inesi G, Lewis D, Toyoshima C, Hirata A, de Meis L (2008) Conformational
fluctuations of the Ca2+-ATPase in the native membrane environment: Effects
of pH, temperature, catalytic substrates, and thapsigargin. J Biol Chem 283:
1189–96.
62. Ferreira ID, Lopes D, Martinelli A, Ferreira C, do Rosa ´rio VE, et al. (2007) In
vitro assessment of artesunate, artemether and amodiaquine susceptibility and
molecular analysis of putative resistance-associated mutations of Plasmodium
falciparum from Sa ˜o Tome ´ and Prı ´ncipe. Trop Med Int Health 12: 353–62.
Polymorphism of Pf-SERCA
PLoS ONE | www.plosone.org 10 February 2010 | Volume 5 | Issue 2 | e942463. Thompson JD, Gibson TJ, Higgins DG (2002) Multiple sequence alignment
using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2: Unit 2.3.
64. Rozas J, Sa ´nchez-Delbarrio JC, Messeguer X, Rozas R (2003) DnaSP, DNA
polymorphism analyses by the coalescent and other methods. Bioinformatics 19:
2496–2497.
65. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) software version 4.0. Molecular Biology and
Evolution 24: 1596–1599.
66. Hudson RR, Slatkin M, Maddison WP (1992) Estimation of levels of gene flow
from DNA sequence data. Genetics 132: 583–589.
67. Templeton AR, Crandall KA, Sing CF (1992) A cladistic analysis of phenotypic
associations with haplotypes inferred from restriction endonuclease mapping and
DNA sequence data. III. Cladogram estimation Genetics 132: 619–633.
Polymorphism of Pf-SERCA
PLoS ONE | www.plosone.org 11 February 2010 | Volume 5 | Issue 2 | e9424